Lb Pharmaceuticals LBRX
NASDAQ LBRX
$44.71 -0.23 (-0.51%)
At close: Nov 11, 2026 · 4:00 PM EST

Lb Pharmaceuticals (LBRX) Net Equity Issued and Repurchased (2025 - 2026)

Updated

Lb Pharmaceuticals' Net Equity Issued and Repurchased came in at $100 million for Q1 2026.

Analysis

Lb Pharmaceuticals (LBRX) Net Equity Issued and Repurchased (2025 - 2026) Analysis & Trends

For FY2025, Lb Pharmaceuticals' Net Equity Issued and Repurchased was $327.75 million, up 719.4% from FY2024.

  • Going back by year, Net Equity Issued and Repurchased was $40 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Lb Pharmaceuticals 1.45 Bn 410.04 Mn - 150.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 150.04 Mn
Jun 30, 2026 48,000.10
Mar 31, 2026 100.03 Mn
Dec 31, 2025 1.17 Mn
Sep 30, 2025 302.32 Mn
API Access

Lb Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=LBRX&period=max&api_key=YOUR_API_KEY